Recent trials in autosomal dominant polycystic kidney disease
After two decades of major achievements in the understanding of genetics and pathophysiology of autosomal dominant polycystic kidney disease (ADPKD) several Stage III randomized and controlled clinical trials involving thousands of patients had the results published recently. In this article, the authors review the results of the major clinical trials discussing the clinical outcomes, adverse effects and limitations as well as the future directions in this exciting investigation.
Saved in:
Main Authors: | Teixeira,Catarina, Costa,Ana Cortesao, Almeida,Edgar A. F. de |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Portuguesa de Nefrologia
2014
|
Online Access: | http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692014000300002 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In utero diagnosis of Autosomal Dominant Polycystic Kidney Disease
by: Cal,Margarida, et al.
Published: (2020) -
Renal and extrarenal manifestations of autosomal dominant polycystic kidney disease
by: Romão,E.A., et al.
Published: (2006) -
Molecular and cellular pathogenesis of autosomal dominant polycystic kidney disease
by: Bastos,A.P., et al.
Published: (2011) -
Caffeine intake by patients with autosomal dominant polycystic kidney disease
by: Vendramini,L.C., et al.
Published: (2012) -
Pain determinants of pain in autosomal dominant polycystic kidney disease
by: Nishiura,José Luiz, et al.
Published: (2013)